Xeris Biopharma Inc.

3.20
-0.02 (-0.62%)
At close: Jan 17, 2025, 3:59 PM
3.24
1.16%
After-hours Jan 17, 2025, 06:13 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 163.91M 110.25M 110.25M 49.59M 20.16M 2.46M 1.56M 1.07M
Cost of Revenue 28.64M 22.63M 22.63M 13.32M 9.33M 42.00K 4.00K 8.00K
Gross Profit 135.27M 87.61M 87.61M 36.27M 10.83M 2.42M 1.55M 1.07M
Operating Income -44.01M -81.94M -81.94M -115.16M -83.55M -59.34M -26.63M -13.23M
Interest Income 4.75M 2.58M 2.58M 313.00K 2.96M 1.61M 124.00K 5.00K
Pretax Income -63.50M -96.08M -96.08M -122.72M -91.25M -60.08M -26.55M -13.21M
Net Income -62.26M -94.66M -94.66M -122.72M -91.14M -60.08M -26.55M -13.21M
Selling & General & Admin 146.09M 137.75M 137.75M 125.72M 73.73M 21.11M 8.02M 4.06M
Research & Development 22.34M 20.97M 20.97M 25.16M 20.92M 40.65M 20.17M 10.24M
Other Expenses 10.84M -14.14M 10.84M 550.00K -280.00K n/a -1K -5.00K
Operating Expenses 179.28M 169.55M 169.55M 151.43M 94.37M 61.77M 28.18M 14.30M
Interest Expense 26.61M 15.32M 15.32M 7.18M 10.66M 2.54M 2.00K 2.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 207.92M 192.19M 192.19M 164.75M 103.70M 61.81M 28.18M 14.31M
Income Tax -1.25M -1.42M -1.42M -110.00K -110.00K 1.81M 1K -3.00K
Shares Outstanding (Basic) 137.67M 135.63M 79.03M 42.64M 26.11M 12.05M 2.03M 1.84M
Shares Outstanding (Diluted) 137.67M 135.63M 79.03M 42.64M 26.11M 12.05M 2.03M 1.84M
EPS (Basic) -0.45 -0.7 -1.2 -2.88 -3.49 -4.99 -13.09 -7.17
EPS (Diluted) -0.45 -0.7 -1.2 -2.88 -3.49 -4.99 -13.09 -7.17
EBITDA -23.73M -69.31M -113.67M -80.08M -117.80M -57.22M -26.38M -13.09M
Depreciation & Amortization 13.16M 12.67M 1.88M 1.47M 1.08M 320.00K 177.00K 116.00K

Create Price Alert on XERS

Your price alert will notify you when the stock price is above 3.20.

Add to Watchlist